Regulation of Signal Transduction at M2 Muscarinic Receptor

Physiological Research

Volumn 53, Issue SUPPL. 1, 2004, Pages

  Krejci A ^a   Michal, P ^a   Jakubik J ^a   Ricny J ^a   Doležal, Vladimír ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Allosteric modulation; Cholinergic transmission; G proteins; Muscarinic receptor subtypes

Indexed keywords

ACETYLCHOLINE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT;

ACETYLCHOLINE RELEASE; ALLOSTERISM; ANIMAL CELL; BINDING AFFINITY; BINDING SITE; CHOLINERGIC TRANSMISSION; CONFORMATIONAL TRANSITION; DRUG DESIGN; EFFECTOR CELL; NERVE CELL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

ACETYLCHOLINE; ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; SIGNAL TRANSDUCTION;

EID: 2342500003     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. BEAN BP: Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature 340: 153-156, 1989.
2. BEECH DJ, BERNHEIM L, HILLE B: Pertussis toxin and voltage dependence distinguish multiple pathways modulating calcium channels of rat sympathetic neurons. Neuron 8: 97-106, 1992.
3. BIRDSALL NJ, LAZARENO S, POPHAM A, SALDANHA J: Multiple allosteric sites on muscarinic receptors. Life Sci 68: 2517-2524, 2001.
4. BONNER TI: New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci Suppl: 11-15, 1989a.
5. BONNER TI: The molecular basis of muscarinic receptor diversity. Trends Neurosci 12: 148-151, 1989b.
6. BONNER TI, BUCKLEY NJ, YOUNG AC, BRANN MR: Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527-532, 1987.
7. 5 muscarinic acetylcholine receptor genes. Neuron 1: 403-410, 1988.
8. BUCKLEY NJ, BONNER TI, BUCKLEY CM, BRANN MR: Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35: 469-476, 1989.
9. αs proteins. Br J Pharmacol 126: 1221-1229, 1999.
10. CLARK AL, MITCHELSON F: The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol 58: 323-331, 1976.
11. 3H]acetylcholine release from rat striatum by muscarinic receptor agonists. Br J Pharmacol 124: 1213-1218, 1998.
12. DOLEŽAL V, TUČEK S: Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatum. Br J Pharmacol 127: 1627-1632, 1999.
13. DOLEŽAL V, TUČEK S, HYNIE S: Effects of pertussis toxin suggest a role for G-proteins in the inhibition of acetylcholine release from rat myenteric plexus by opioid and presynaptic muscarinic receptors. Eur J Neurosci 1: 127-131, 1989.
14. DOLPHIN AC: G protein modulation of calcium currents in neurons. Annu Rev Physiol 52: 243-255, 1990.
15. DUNLAP J, BROWN JH: Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Mol Pharmacol 24: 15-22, 1983.
16. 2A-adrenergic receptor. J Biol Chem 270: 24753-24760, 1995.
17. 2-adrenergic receptors to two G-proteins with opposing effects. J Biol Chem 267: 15795-15801, 1992.
18. EGLEN RM, MONTGOMERY WW, WHITING RL: Negative and positive inotropic responses to muscarinic agonists in guinea pig atria in vitro. J Pharmacol Exp Ther 247: 911-917, 1988.
19. 2-adrenergic receptor in Chinese hamster ovary cells. J Biol Chem 264: 11754-11761, 1989.
20. 5) expressed in baculovirus-infected insect cells. J Pharmacol Exp Ther 274: 378-384, 1995.
21. 2+ channels by G-protein beta gamma subunits. Nature 380: 258-162, 1996.
22. HILLE B: G protein-coupled mechanisms and nervous signaling. Neuron 9: 187-195, 1992.
23. HILLE B: Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci 17: 531-536, 1994.
24. ILLES P: Mechanisms of receptor-mediated modulation of transmitter release in noradrenergic, cholinergic and sensory neurones. Neuroscience 17: 909-928, 1986.
25. IMAI S, OHTA H: Positive inotropic effects induced by carbachol in rat atria treated with islet-activating protein (IAP) - association with phosphatidylinositol breakdown. Br J Pharmacol 94: 347-354, 1982.
26. 5 muscarinic acetylcholine receptors. J Pharmacol Exp Ther 274: 1077-1083, 1995.
27. JAKUBÍK J, BAČÁKOVÁ L, LISÁ V, EL-FAKAHANY EE, TUČEK S: Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc Natl Acad Sci USA 93: 8705-8709, 1996.
28. JAKUBÍK J, BAČÁKOVÁ L, EL-FAKAHANY EE, TUČEK S: Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol Pharmacol 52: 172-179, 1997.
29. o protein stoichiometry. Mol Pharmacol 54: 899-906, 1998.
30. JONES SV: Muscarinic receptor subtypes: modulation of ion channels. Life Sci 52: 457-464, 1993.
31. JONES SV, HEILMAN CJ, BRANN MR: Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 40: 242-247, 1991.
32. KAWASHIMA K, FUJII T: Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86: 29-48, 2000.
33. KAWASHIMA K, FUJII T: The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 74: 675-696, 2003.
34. KAWASHIMA K, OOHATA H, FUJIMOTO K, SUZUKI T: Extraneuronal localization of acetylcholine and its release upon nicotinic stimulation in rabbits. Neurosci Lett 104: 336-339, 1989.
35. KAWASHIMA K, WATANABE N, OOHATA H, FUJIMOTO K, SUZUKI T, ISHIZAKI Y, MORITA I, MUROTA S: Synthesis and release of acetylcholine by cultured bovine arterial endothelial cells. Neurosci Lett 119: 156-158, 1990.
36. KENAKIN TP, BOSELLI C: Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists. Eur J Pharmacol 191: 39-48, 1990.
37. 3 receptors. Mol Pharmacol 60: 761-767, 2001.
38. 5 subtypes of muscarinic receptors in rat heart and brain cortex. Mol Pharmacol 61: 1267-1272, 2002.
39. LAZARENO S, BIRDSALL NJ: Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48: 362-378, 1995.
40. 3H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site. Mol Pharmacol 58: 194-207, 2000.
41. LAZARENO S, POPHAM A, BIRDSALL NJ: Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors. Mol Pharmacol 62: 1492-1505, 2002.
42. 2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists. Br J Pharmacol 132: 1217-1228, 2001.
43. 2. J Biol Chem 269: 9767-9773, 1994.
44. MILLER RJ: Multiple calcium channels and neuronal function. Science 235: 46-52, 1987.
45. MIROTZNIK RR, ZHENG X, STANLEY EF: G-Protein types involved in calcium channel inhibition at a presynaptic nerve terminal. J Neurosci 20: 7614-7621, 2000.
46. MOLENAAR P, POLAK RL: Inhibition of acetylcholine release by activation of acetylcholine receptors. Prog Pharmacol 3/4: 39-44, 1980.
47. 2-adrenergic receptors determines subtypes-specific coupling to cAMP production. J Biol Chem 272: 9703-9708, 1997.
48. NEDOMA J, DOROFEEVA NA, TUČEK S, SHELKOVNIKOV SA, DANILOV AF: Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum. Naunyn Schmiedebergs Arch Pharmacol 329: 176-181, 1985.
49. NEDOMA J, TUČEK S, DANILOV AF, SHELKOVNIKOV SA: Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs. J Pharmacol Exp Ther 236: 219-223, 1986.
50. 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells. Mol Pharmacol 44: 802-809, 1993.
51. PERALTA EG, ASHKENAZI A, WINSLOW JW, SMITH DH, RAMACHANDRAN J, CAPON DJ: Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 9: 3923-3929, 1987.
52. PERNEY TM, HIRNING LD, LEEMAN SE, MILLER RJ: Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc Natl Acad Sci USA 83: 6656-6659, 1986.
53. PROŠKA J, TUČEK S: Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol Pharmacol 45: 709-717, 1994.
54. i1α fusion protein. FEBS Lett 436: 46-50, 1998.
55. STARKE K, GÖTHERT M, KILBINGER H: Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69: 864-989, 1989.
56. STOCKTON JM, BIRDSALL NJ, BURGEN AS, HULME EC: Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23: 551-557, 1983.
57. TUČEK S, DOLEŽAL V, FOLBERGROVÁ J, HYNIE S, KOLÁŘ F, OŠŤÁDAL B: Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart. Pflugers Arch 408: 167-172, 1987.
58. TUČEK S, MUSÍLKOVÁ J, NEDOMA J, PROŠKA J, SHELKOVNIKOV S, VORLÍČEK J: Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol Pharmacol 38: 674-680, 1990.
59. TUČEK S, JAKUBÍK J, DOLEŽAL V, EL-FAKAHANY EE: Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors. J Physiol Paris 92: 241-243, 1998.
60. 2 receptors on the synthesis of cyclic AMP in CHO cells: background and model. Life Sci 68: 2501-2510, 2001.
61. TUČEK S, MICHAL P, VLACHOVÁ V: Modelling the consequences of receptor-G-protein promiscuity. Trends Pharmacol Sci 23: 171-176, 2002.
62. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 90: 9518-9522, 1993.
63. 2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells. J Biol Chem 270: 15485-15493, 1995.
64. WEBB WW, PAPPANO AJ: Muscarinic agonist-induced positive inotropic response in chick atria. Life Sci 57: 2365-2376, 1995.
65. WESSLER I, KIRKPATRICK CJ, RACKE K: Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77: 59-79, 1998.
66. WESSLER I, KILBINGER H, BITTINGER F, KIRKPATRICK CJ: The biological role of non-neuronal acetylcholine in plants and humans. Jpn J Pharmacol 85: 2-10, 2001.
67. ZHANG W, BASILE AS, GOMEZA J, VOLPICELLI LA, LEVEY AI, WESS J: Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 22: 1709-1717, 2002.